Answer
The most commonly reported side effects of roflumilast for COPD are diarrhoea (5.9%), weight loss (3.4%), nausea (2.9%), abdominal pain (1.9%) and headache (1.7%), mainly occurring during the first weeks and mostly resolving with continued treatment.
Sources for this answer
- DAXAS 500 micrograms film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.8 Undesirable effects · Version 16Document updated
Sources checked